BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 1, 2026
Home » Authors » Sergio Held

Articles by Sergio Held

Latin America: Reimbursement appears to be a lost word in Latin American markets

July 15, 2014
By Sergio Held

Improving traceability: Argentina takes global lead fighting fakes

July 11, 2014
By Sergio Held
BOGOTA, Colombia – A relatively young system to trace pharmaceutical products from manufacturer to patient has put Argentina at the forefront of the global fight against fake drugs.
Read More

Latin America: With new regulations, Argentina premieres sterile traceability

July 7, 2014
By Sergio Held

Colombia premieres nuclear technology that boosts radiopharma production

June 30, 2014
By Sergio Held

Latin America: University developing nanotechnology innovations for the med-tech sector

June 23, 2014
By Sergio Held

Moksha8 and Biopas join forces to conquer the LatAm market

June 20, 2014
By Sergio Held
BOGOTA, Colombia – A pair of specialty biopharma companies have launched an alliance with the end goal of reaching deep into the growing but often difficult-to-tap markets across Latin America.
Read More

As Latin American agencies join forces, approvals may speed up

June 16, 2014
By Sergio Held
BOGOTA, Colombia – A group of regulatory agencies from Latin America are joining forces to strengthen cooperation, enhance their regulatory capacity and speed up approvals by sharing more information, improving communication channels and mutually recognizing certifications and approvals.
Read More

Boston Sci opens new facilities for endoscopists in Europe

June 13, 2014
By Sergio Held
Looking to penetrate deeper into European markets and cement relationships with the doctors and healthcare practitioners that use their devices the most, international device maker Boston Scientific (Natick, Massachusetts) opened a new training facility in Paris last week.
Read More

Latin America: Costa Rican med-tech sector bolstered by S&N's acquisiton of Arthrocare

June 6, 2014
By Sergio Held

Latin America: Confident in Lat Am market, Australia's Compumedics heads to Brazil

June 5, 2014
By Sergio Held
Previous 1 2 … 24 25 26 27 28 29 30 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 1, 2026.
  • Floating antibody drug conjugates

    TROP2 ADCs progress into first-line for lung, breast cancers

    BioWorld
    Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
  • Illustration of antibodies and viral infection

    New evidence links autoimmunity to long COVID symptoms

    BioWorld
    Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
  • Liver with hepatitis viruses, blood cells

    Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections

    BioWorld
    GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
  • Healthy (left) vs. cancerous bone marrow

    BMS’ mezigdomide doubles PFS in multiple myeloma

    BioWorld
    Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing